Curcumin inhibits the proliferation and invasiveness of MHCC97-H cells via p38 signaling pathway

Drug Dev Res. 2014 Nov;75(7):463-8. doi: 10.1002/ddr.21210. Epub 2014 Sep 4.

Abstract

Curcumin has been reported to be effective as a cancer therapy. However, the anti-metastatic effect and molecular mechanism(s) of curcumin in hepatocellular carcinoma (HCC) remain poorly understood. The purpose of this study was to test the effects of curcumin on HCC and its putative mechanism(s). Curcumin inhibited the proliferation of HCC cells and inhibited the migration and invasion of these cells at sub-cytotoxic concentrations. Curcumin also decreased the expression and activity of matrix metalloproteinases (MMP)-2 and MMP-9, and reduced p38 phosphorylation. Combination treatment of HCC cells with curcumin and SB203580 (a p38 signaling pathway inhibitor), generated a synergistic effect on the expression of MMP-2 and MMP-9, suggesting that the anti-metastatic effect of curcumin on HCC may involve a p38 signaling pathway.

Keywords: MMP; curcumin; hepatocellular carcinoma; migration and invasion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Carcinoma, Hepatocellular / enzymology
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology*
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects*
  • Curcumin / pharmacology*
  • Drug Synergism
  • Humans
  • Imidazoles / pharmacology
  • Liver Neoplasms / metabolism
  • MAP Kinase Signaling System / drug effects*
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Neoplasm Invasiveness / prevention & control*
  • Phosphorylation / drug effects
  • Pyridines / pharmacology

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Pyridines
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Curcumin
  • SB 203580